Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
•
Primary Care
When do you consider lifelong AIT?
Related Questions
How do you manage recurrent epistaxis from nasal steroids?
What methods have you found successful in getting young children to use nasal sprays?
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
Do you routinely take a cancer history from patients being evaluated for atopy?
Does a diagnosis of NARES change your management of rhinitis?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Do you recommend patients try antihistamines such as oral ketotifen that are not approved in the US but are approved in the EU for MCAS if currently available formulations have not been effective?
